Neurotrophic factors are essential proteins that support neuronal survival, differentiation, synaptic plasticity, and function. Decline in neurotrophic signaling is a common feature of Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and other neurodegenerative disorders. This page examines the major neurotrophic systems, their dysfunction in neurodegenerative diseases, and therapeutic strategies to restore neurotrophic support 1.
BDNF is the most widely studied neurotrophin in the brain:
- Receptors: TrkB (high affinity), p75NTR (low affinity)
- Signaling: TrkB autophosphorylation activates PI3K/Akt, MAPK/ERK, and PLCγ pathways
- Functions: Neuronal survival, synaptic plasticity, memory formation
- Expression: High in hippocampus and cortex
NGF was the first discovered neurotrophic factor:
- Receptors: TrkA (high affinity), p75NTR
- Signaling: TrkA activates similar pathways to TrkB
- Functions: Cholinergic neuron survival, peripheral innervation
- Expression: Basal forebrain cholinergic neurons
GDNF family ligands support dopaminergic and motor neurons:
- Receptors: GFRα1-4 (GPI-anchored), Ret (coreceptor)
- Signaling: GFRα/Ret complex activates PI3K/Akt and MAPK pathways
- Functions: Dopaminergic neuron survival, motor neuron support
- Expression: Midbrain, spinal cord
- Neurotrophin-3 (NT-3): Supports diverse neuronal populations
- Neurotrophin-4 (NT-4): Synaptic plasticity
- Ciliary Neurotrophic Factor (CNTF): Astrocyte-derived, neuroprotection
- Insulin-like Growth Factor (IGF-1): Metabolic and trophic support
- VEGF: Angiogenesis and neuroprotection
flowchart TD
A[Neurotrophic Factor] --> B[Trk Receptor Dimerization]
A --> C[p75NTR Receptor]
B --> D[Trk Autophosphorylation]
D --> E[PI3K/Akt Pathway]
D --> F[MAPK/ERK Pathway]
D --> G[PLCγ Pathway]
E --> H[Cell Survival]
E --> I[Protein Synthesis]
F --> J[Gene Expression]
F --> K[Neurite Outgrowth]
G --> L[Calcium Signaling]
L --> H
C --> M[NF-κB Activation]
C --> N[Apoptosis]
M --> H
N --> O[Cell Death]
BDNF dysfunction is a key feature in AD:
BDNF levels: Reduced BDNF in AD brain, particularly in hippocampus. Serum BDNF correlates with cognitive decline 2.
TrkB signaling: Impaired TrkB signaling contributes to synaptic loss. Aβ disrupts TrkB signaling.
p75NTR signaling: Increased p75NTR expression promotes apoptosis in AD.
Cholinergic system: NGF support is impaired in basal forebrain cholinergic neurons.
Therapeutic implications: BDNF delivery shows promise in preclinical models.
Key neurotrophins in AD:
- BDNF: Reduced hippocampal expression
- NGF: Impaired retrograde transport
- NT-3: Altered expression
GDNF and BDNF support is critical for dopaminergic neurons:
GDNF: Highly protective of dopaminergic neurons. Clinical trials showed mixed results.
BDNF: Supports dopaminergic neuron survival. Reduced in PD substantia nigra.
GFRα signaling: GDNF family receptor dysfunction in PD.
Retrograde transport: Impaired transport of trophic factors.
Key genes in PD neurotrophin signaling:
- GDNF - Glial cell line-derived neurotrophic factor
- RET - GDNF receptor
- GFRΑ1 - GDNF family receptor alpha 1
Neurotrophic support is critical for motor neurons:
CNTF: CNTF levels reduced in ALS. CNTF knockout mice develop motor neuron disease.
GDNF: Protective of motor neurons. Delivered via gene therapy in trials.
BDNF: Supports motor neurons. Clinical trials showed limited efficacy.
VEGF: Motor neuron protection. VEGF deficiency increases ALS risk.
Key genes in ALS neurotrophin signaling:
- CNTF - Ciliary neurotrophic factor
- VEGFΑ - Vascular endothelial growth factor A
- GDNF - Glial cell line-derived neurotrophic factor
- cAMP response element-binding protein (CREB): Reduced CREB activity
- Activity-dependent expression: Reduced neuronal activity
- Epigenetic changes: DNA methylation affects neurotrophin genes
- Transcription factor dysfunction: Reduced Npas1, Npas4
See Epigenetic Alterations in Neurodegeneration for detailed information.
- Axonal transport defects: Neurotrophin cargo fails to reach cell bodies
- Cytoskeletal disruption: Tau pathology affects transport
- Molecular motor dysfunction: Kinesin/dynein impairment
- TrkB cleavage: Aβ promotes TrkB shedding
- Receptor trafficking: Impaired sorting to membranes
- Downstream signaling: PI3K/Akt pathway impairment
- Neuroinflammation: Glia become less supportive
- Oxidative stress: Damages neurotrophin expression systems
- Metabolic dysfunction: Reduces neurotrophin production
BDNF delivery:
- Recombinant protein delivery
- AAV gene therapy
- Cell-based delivery
GDNF delivery:
- Intraputaminal infusion (clinical trials)
- AAV gene therapy
- Protein delivery
NGF delivery:
- Cholinergic neuron support
- AAV gene therapy approaches
TrkB agonists:
- 7,8-DHF (7,8-dihydroxyflavone)
- BDNF mimetics
- Amitriptyline (TrkB activator)
GDNF family agonists:
- Small molecule GFRα1 agonists
- Ret agonists
PI3K/Akt activators:
- Akt activators
- mTOR modulators
CREB activators:
- Phosphodiesterase inhibitors
- CREB-binding protein (CBP) modulators
- AAV-BDNF: In clinical trials
- AAV-GDNF: In clinical trials
- AAV-NT-3: Preclinical
- Cell-based delivery: Stem cells engineered to secrete neurotrophins
¶ Lifestyle and Environmental Factors
- Exercise: Increases BDNF expression
- Cognitive stimulation: Activity-dependent BDNF
- Diet: Caloric restriction, omega-3 fatty acids
- Sleep: Sleep deprivation reduces BDNF
- BDNF - Brain-derived neurotrophic factor
- NGF - Nerve growth factor
- GDNF - Glial cell line-derived neurotrophic factor
- NTF3 - Neurotrophin-3
- NTF4 - Neurotrophin-4
- CNTF - Ciliary neurotrophic factor
- VEGFA - Vascular endothelial growth factor A
- NTRK2 - TrkB receptor
- NTRK1 - TrkA receptor
- RET - GDNF receptor
- GFRA1 - GFRα1 receptor
- CREB1 - CREB transcription factor
- Holtman et al., Neurotrophic Factors in Neurodegeneration (2019)
- Peng et al., BDNF in AD (2019)
- Allen et al., GDNF in PD (2019)
- S久 et al., BDNF and Synaptic Plasticity (2018)
- Saragovi et al., Trk Receptor Agonists (2018)
- Kumar et al., Neurotrophin Gene Therapy (2019)
- Weissmiller & Wu, p75NTR in Neurodegeneration (2018)
- Bolognin et al., Neurotrophic Factors in AD Therapy (2018)